lysophosphatidic acid has been researched along with cytochalasin d in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fishman, DA; Kang, S; Meng, Y | 1 |
| Liu, Y; Ma, T; Tsai, AC; Yuan, X | 1 |
2 other study(ies) available for lysophosphatidic acid and cytochalasin d
| Article | Year |
|---|---|
Lysophosphatidic acid inhibits anti-Fas-mediated apoptosis enhanced by actin depolymerization in epithelial ovarian cancer.
Topics: Actins; Antibodies; Apoptosis; bcl-Associated Death Protein; Carrier Proteins; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cytochalasin D; Cytoskeleton; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; fas Receptor; Female; Humans; Lysophospholipids; Ovarian Neoplasms; Phosphorylation | 2005 |
Compaction, fusion, and functional activation of three-dimensional human mesenchymal stem cell aggregate.
Topics: Actins; Amides; Caspase Inhibitors; Caspases; Cell Adhesion; Cell Aggregation; Cell Communication; Cell Culture Techniques; Cell Fusion; Cell Hypoxia; Cell Movement; Cell Shape; Cell Size; Cell Survival; Cytochalasin D; Humans; Lysophospholipids; Mesenchymal Stem Cells; Nocodazole; Pyridines; rho-Associated Kinases | 2015 |